美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
17856-0024-1	17856-0024	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	POWDER, FOR SUSPENSION	ORAL	20230411	N/A	ANDA	ANDA202333	ATLANTIC BIOLOGICALS CORP.	SODIUM POLYSTYRENE SULFONATE	4.1 meq/g	50 CUP in 1 BOX, UNIT-DOSE (17856-0024-1) / 15 g in 1 CUP (17856-0024-3)
17856-0024-2	17856-0024	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	POWDER, FOR SUSPENSION	ORAL	20230411	N/A	ANDA	ANDA202333	ATLANTIC BIOLOGICALS CORP.	SODIUM POLYSTYRENE SULFONATE	4.1 meq/g	50 CUP in 1 BOX, UNIT-DOSE (17856-0024-2) / 30 g in 1 CUP (17856-0024-4)
24658-760-16	24658-760	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	POWDER, FOR SUSPENSION	ORAL	20161215	N/A	ANDA	ANDA202333	PuraCap Laboratories, LLC	SODIUM POLYSTYRENE SULFONATE	4.1 meq/g	453.6 g in 1 JAR (24658-760-16)
42806-013-94	42806-013	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	POWDER, FOR SUSPENSION	ORAL	20220915	N/A	ANDA	ANDA202333	Epic Pharma, LLC	SODIUM POLYSTYRENE SULFONATE	4.1 meq/g	15 g in 1 BOTTLE (42806-013-94)
42806-013-96	42806-013	HUMAN PRESCRIPTION DRUG	Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	POWDER, FOR SUSPENSION	ORAL	20140414	N/A	ANDA	ANDA202333	Epic Pharma, LLC	SODIUM POLYSTYRENE SULFONATE	4.1 meq/g	453.6 g in 1 JAR (42806-013-96)